Quantitative model demonstrating that recombinant adeno‐associated virus and green fluorescent protein are non‐toxic to the rat retina
- 26 September 2003
- journal article
- research article
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 31 (5) , 439-444
- https://doi.org/10.1046/j.1442-9071.2003.00693.x
Abstract
Background: Recombinant adeno‐associated virus (rAAV) is one of the most promising recombinant viral vectors for delivering therapeutic agents to the retina. The present study aims to quantify any effect that an rAAV construct may have on the retina. To be able to use rAAV for therapeutic purposes, the potentially toxic effect of the vector and an associated green fluorescent protein (gfp) marker has to be investigated. Methods: By combining histological analysis with computer scanning techniques, the local toxicity of rAAV and gfp can be measured. This will have obvious implications for its role as a carrier in the rapidly developing world of gene therapy. Results: It is shown that a construct consisting of rAAV and gfp, delivered subretinally to rat eyes, causes no more histological damage than injection with saline alone. Furthermore, via fluorescent fundus photography and computer scanning techniques it is seen that the area exposed to the rAAV−gfp construct is significantly greater than the area of histological change. Conclusions: It is thus concluded that the rAAV−gfp construct has no significant toxic effect, at an anatomical level, on the retina 12 months after injection.Keywords
This publication has 17 references indexed in Scilit:
- Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD miceProceedings of the National Academy of Sciences, 2001
- Transduction of ovarian cancer cells: a recombinant adeno-associated viral vector compared to an adenoviral vectorBritish Journal of Cancer, 2001
- Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectorsGene Therapy, 2001
- Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retinaProceedings of the National Academy of Sciences, 1999
- Development of gene therapy-based strategies for the treatment of eye diseasesDrug Development Research, 1999
- Evaluation of Adeno-Associated Virus-Mediated Gene Transfer into the Rat Retina by Clinical Fluorescence PhotographyHuman Gene Therapy, 1999
- Autosomal recessive retinal dystrophy associated with two novel mutations in the RPE65 geneEuropean Journal of Human Genetics, 1998
- Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virusProceedings of the National Academy of Sciences, 1997
- AAV as a viral vector for human gene therapyMolecular Biotechnology, 1995
- Prospects for the Use of Adeno-Associated Virus as a Vector for Human Gene TherapyHuman Gene Therapy, 1994